GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Cyclically Adjusted PS Ratio

Glycorex Transplantation AB (NGM:GTAB B) Cyclically Adjusted PS Ratio : 4.20 (As of Jul. 05, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Glycorex Transplantation AB Cyclically Adjusted PS Ratio?

As of today (2025-07-05), Glycorex Transplantation AB's current share price is kr2.27. Glycorex Transplantation AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr0.54. Glycorex Transplantation AB's Cyclically Adjusted PS Ratio for today is 4.20.

The historical rank and industry rank for Glycorex Transplantation AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

NGM:GTAB B' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.45   Med: 3.96   Max: 11.05
Current: 4.32

During the past years, Glycorex Transplantation AB's highest Cyclically Adjusted PS Ratio was 11.05. The lowest was 1.45. And the median was 3.96.

NGM:GTAB B's Cyclically Adjusted PS Ratio is ranked better than
56.94% of 490 companies
in the Biotechnology industry
Industry Median: 5.615 vs NGM:GTAB B: 4.32

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Glycorex Transplantation AB's adjusted revenue per share data for the three months ended in Mar. 2025 was kr0.125. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr0.54 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Glycorex Transplantation AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Glycorex Transplantation AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glycorex Transplantation AB Cyclically Adjusted PS Ratio Chart

Glycorex Transplantation AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 7.16 2.33 3.72

Glycorex Transplantation AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.51 1.86 3.94 3.72 3.70

Competitive Comparison of Glycorex Transplantation AB's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Glycorex Transplantation AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glycorex Transplantation AB's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glycorex Transplantation AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Glycorex Transplantation AB's Cyclically Adjusted PS Ratio falls into.


;
;

Glycorex Transplantation AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Glycorex Transplantation AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2.27/0.54
=4.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Glycorex Transplantation AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Glycorex Transplantation AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.125/132.8245*132.8245
=0.125

Current CPI (Mar. 2025) = 132.8245.

Glycorex Transplantation AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.114 99.995 0.151
201509 0.118 100.228 0.156
201512 0.123 100.276 0.163
201603 0.145 100.751 0.191
201606 0.105 101.019 0.138
201609 0.102 101.138 0.134
201612 0.148 102.022 0.193
201703 0.123 102.022 0.160
201706 0.106 102.752 0.137
201709 0.106 103.279 0.136
201712 0.107 103.793 0.137
201803 0.147 103.962 0.188
201806 0.107 104.875 0.136
201809 0.098 105.679 0.123
201812 0.144 105.912 0.181
201903 0.150 105.886 0.188
201906 0.106 106.742 0.132
201909 0.146 107.214 0.181
201912 0.115 107.766 0.142
202003 0.105 106.563 0.131
202006 0.044 107.498 0.054
202009 0.118 107.635 0.146
202012 0.099 108.296 0.121
202103 0.067 108.360 0.082
202106 0.108 108.928 0.132
202109 0.116 110.338 0.140
202112 0.092 112.486 0.109
202203 0.093 114.825 0.108
202206 0.151 118.384 0.169
202209 0.118 122.296 0.128
202212 0.127 126.365 0.133
202303 0.095 127.042 0.099
202306 0.123 129.407 0.126
202309 0.083 130.224 0.085
202312 0.104 131.912 0.105
202403 0.109 132.205 0.110
202406 0.124 132.716 0.124
202409 0.101 132.304 0.101
202412 0.142 132.987 0.142
202503 0.125 132.825 0.125

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Glycorex Transplantation AB  (NGM:GTAB B) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Glycorex Transplantation AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Glycorex Transplantation AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Glycorex Transplantation AB Business Description

Traded in Other Exchanges
Address
Solvegatan 41, Lund, SWE, 223 70
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Glycorex Transplantation AB Headlines

No Headlines